EFEKTIVITAS VAGAL NERVE STIMULATION (VNS) TERHADAP DISRITMIA JANTUNG
نویسندگان
چکیده
منابع مشابه
Clinical Policy Title: Vagus nerve stimulation (VNS)
ABOUT THIS POLICY: AmeriHealth Caritas Louisiana has developed clinical policies to assist with making coverage determinations. AmeriHealth Caritas Louisiana’s clinical policies are based on guidelines from established industry sources, such as the Centers for Medicare & Medicaid Services (CMS), state regulatory agencies, the American Medical Association (AMA), medical specialty professional so...
متن کاملEffectiveness of vagal nerve stimulation (VNS) in patients with drop-attacks and different epileptic syndromes
PURPOSE The effectiveness of VNS was evaluated in thirty-nine encephalopatic patients with drug-resistant epilepsy characterized by multiple seizures and drop attacks. Twenty-five patients were affected by severe epilepsy with multiple independent spike foci (SE-MISF) and fourteen patients by Lennox-Gastaut syndrome (LGS). METHOD Changes in seizure frequency, cognition, adaptive behaviour and...
متن کاملVagal nerve stimulation—the Norwegian experience
The purpose of this open retrospective study was to analyze the efficacy and tolerability of vagal nerve stimulation (VNS) in a Norwegian cohort of referral patients with refractory epileptic seizures. A total of 47 patients have been assessed after a mean follow-up time of 2.7 years. Mean age was 34.4 years, mean duration of epilepsy was 25.3 years. Forty-two patients (89%) had localization-re...
متن کاملPredicting success of vagus nerve stimulation (VNS) from interictal EEG
PURPOSE Vagus nerve stimulation (VNS) has shown to be an effective treatment for drug resistant epilepsy in numerous patients, however, not in all. It is still not possible to predict which patients will profit from VNS. In this pilot study, we explore predictive interictal EEG features for seizure reduction after VNS. METHODS 19 Patients with medically refractory epilepsy and an implanted VN...
متن کاملVagal nerve stimulation in heart failure.
It has been estimated that the prevalence of heart failure with a reduced ejection fraction exceeds 20 million patients worldwide— about 2% of the general population in the Western world—and that the annual incidence is . 2 million patients per year. The mortality of heart failure exceeds that of many malignancies. Significant healthcare improvements have been made with regard to pharmaceutical...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Jurnal Sahabat Keperawatan
سال: 2020
ISSN: 2656-1115
DOI: 10.32938/jsk.v2i01.400